Ioversol
Radiographic Contrast Agent — VARIOUS
Also known as: joversol, MP-328
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Ioversol is an ofp drug in the Radiographic Contrast Agent class catalogued in DrugCentral. It was first approved by the FDA in 1988. Its mechanism of action is classified as X-Ray Contrast Activity.
- Approval status: ofp (first approved 1988 by the FDA).
- Drug class: Radiographic Contrast Agent.
- Mechanism of action: X-Ray Contrast Activity.
- ATC code: V08AB07 (Watersoluble, nephrotropic, low osmolar X-ray contrast media).
- Molecular formula: C18H24I3N3O9; molecular weight 807.11 g/mol.
Mechanism & targets
| Mechanism of action (MoA) | X-Ray Contrast Activity |
|---|---|
| Established pharmacologic class | Radiographic Contrast Agent |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1988-12-30 | FDA | — | LIEBEL-FLARSHEIM |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
V08AB07 | VARIOUS › CONTRAST MEDIA › X-RAY CONTRAST MEDIA, IODINATED › Watersoluble, nephrotropic, low osmolar X-ray contrast media |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Urticaria | 1063.2 |
| Sneezing | 664.6 |
| Nephropathy toxic | 595.5 |
| Pruritus | 572.7 |
| Throat irritation | 564.4 |
| Anaphylactic shock | 433.1 |
| Throat tightness | 379.1 |
| Dyspnoea | 339.3 |
| Contrast media reaction | 324.6 |
| Air embolism | 284.7 |
| Erythema | 278.5 |
| Chest discomfort | 232.5 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Ioversol is on its molecule page.
| Molecular formula | C18H24I3N3O9 |
|---|---|
| Molecular weight | 807.11 g/mol |
| CAS number | — |
| InChIKey | AMDBBAQNWSUWGN-UHFFFAOYSA-N |
| PubChem CID | 3741 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Ioversol work?
Ioversol is classified as X-Ray Contrast Activity.
When was Ioversol first approved?
Ioversol was first approved by the FDA in 1988.
What drug class does Ioversol belong to?
Ioversol is in the Radiographic Contrast Agent class.
What is the chemical formula of Ioversol?
Ioversol has the molecular formula C18H24I3N3O9 and a molecular weight of 807.11 g/mol.
Browse: all drugs starting with I · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1471 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200614 — compound record and bioactivity
- PubChem CID 3741 — chemical identifiers
- DrugBank DB09134 — drug record
- FDA UNII N3RIB7X24K — substance identity
- DailyMed: FDA labels for Ioversol — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.